Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Quinaprilat
Drug ID BADD_D01892
Description The active metabolite of the prodrug [quinapril].
Indications and Usage Not Available
Marketing Status experimental
ATC Code Not Available
DrugBank ID DB14217
KEGG ID D03773
MeSH ID C054501
PubChem ID 107994
TTD Drug ID Not Available
NDC Product Code Not Available
UNII 34SSX5LDE5
Synonyms quinaprilat | 2-(2-((1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid | quinaprilat, (3S-(2(R*(R*)),3R*))-isomer | CI 928 | CI-928
Chemical Information
Molecular Formula C23H26N2O5
CAS Registry Number 82768-85-2
SMILES CC(C(=O)N1CC2=CC=CC=C2CC1C(=O)O)NC(CCC3=CC=CC=C3)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dizziness24.06.02.007; 17.02.05.003; 02.11.04.0060.011057%
Drug hypersensitivity10.01.01.0010.188507%Not Available
Drug ineffective08.06.01.0060.025195%Not Available
Drug interaction08.06.03.0010.001813%Not Available
Dry mouth07.06.01.002--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.11.05.003--
Erythema23.03.06.0010.003988%Not Available
Fatigue08.01.01.002--
Feeling abnormal08.01.09.014--Not Available
Flatulence07.01.04.002--
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Gastrointestinal pain07.01.05.005--
Haemolytic anaemia01.06.03.002--Not Available
Headache17.14.01.0010.011057%
Hepatitis09.01.07.004--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperkalaemia14.05.03.001--
Hypersensitivity10.01.03.0030.003988%
Hypertension24.08.02.0010.005800%
Hypertensive crisis24.08.01.001--Not Available
Hyponatraemia14.05.04.0020.001813%
Injection site pain12.07.03.011; 08.02.03.0100.001813%Not Available
Insomnia19.02.01.002; 17.15.03.002--
Kaposi's sarcoma16.33.02.001; 11.05.17.0010.005438%Not Available
Laryngeal oedema22.04.02.001; 23.04.01.005; 10.01.05.003--
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.0050.003988%Not Available
Liver function test abnormal13.03.04.030--Not Available
Loss of consciousness17.02.04.004--Not Available
Malaise08.01.01.003--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages